9-94084637-A-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001253829.2(PTPDC1):āc.107A>Gā(p.Gln36Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000117 in 1,613,306 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 33)
Exomes š: 0.00011 ( 0 hom. )
Consequence
PTPDC1
NM_001253829.2 missense
NM_001253829.2 missense
Scores
1
3
13
Clinical Significance
Conservation
PhyloP100: 4.17
Genes affected
PTPDC1 (HGNC:30184): (protein tyrosine phosphatase domain containing 1) The protein encoded by this gene contains a characteristic motif of protein tyrosine phosphatases (PTPs). PTPs regulate activities of phosphoproteins through dephosphorylation. They are signaling molecules involved in the regulation of a wide variety of biological processes. The specific function of this protein has not yet been determined. Alternatively spliced transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.043582946).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PTPDC1 | NM_001253829.2 | c.107A>G | p.Gln36Arg | missense_variant | 1/9 | ENST00000620992.5 | |
PTPDC1 | NM_152422.4 | c.107A>G | p.Gln36Arg | missense_variant | 1/9 | ||
PTPDC1 | NM_001253830.2 | c.83-614A>G | intron_variant | ||||
PTPDC1 | NM_177995.3 | c.83-614A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PTPDC1 | ENST00000620992.5 | c.107A>G | p.Gln36Arg | missense_variant | 1/9 | 2 | NM_001253829.2 | ||
PTPDC1 | ENST00000288976.3 | c.107A>G | p.Gln36Arg | missense_variant | 1/9 | 1 | |||
PTPDC1 | ENST00000375360.7 | c.83-614A>G | intron_variant | 1 | P1 | ||||
PTPDC1 | ENST00000650567.1 | c.83-614A>G | intron_variant | P1 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152252Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
25
AN:
152252
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000173 AC: 43AN: 248270Hom.: 0 AF XY: 0.000171 AC XY: 23AN XY: 134818
GnomAD3 exomes
AF:
AC:
43
AN:
248270
Hom.:
AF XY:
AC XY:
23
AN XY:
134818
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000112 AC: 164AN: 1461054Hom.: 0 Cov.: 31 AF XY: 0.000118 AC XY: 86AN XY: 726828
GnomAD4 exome
AF:
AC:
164
AN:
1461054
Hom.:
Cov.:
31
AF XY:
AC XY:
86
AN XY:
726828
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000164 AC: 25AN: 152252Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74396
GnomAD4 genome
AF:
AC:
25
AN:
152252
Hom.:
Cov.:
33
AF XY:
AC XY:
14
AN XY:
74396
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
20
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2024 | The c.107A>G (p.Q36R) alteration is located in exon 1 (coding exon 1) of the PTPDC1 gene. This alteration results from a A to G substitution at nucleotide position 107, causing the glutamine (Q) at amino acid position 36 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Benign
.;N
REVEL
Benign
Sift
Uncertain
.;D
Sift4G
Pathogenic
D;D
Polyphen
0.047
.;B
Vest4
MutPred
Gain of helix (P = 0.0325);Gain of helix (P = 0.0325);
MVP
MPC
0.53
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at